Next Article in Journal
Pfizer-BioNTech mRNA Vaccine Protection among Children and Adolescents Aged 12–17 Years against COVID-19 Infection in Qatar
Next Article in Special Issue
Testing a Recombinant Form of Tetanus Toxoid as a Carrier Protein for Glycoconjugate Vaccines
Previous Article in Journal
Generation of a DSF-Guided Refolded Bacterially Expressed Hemagglutinin Ectodomain of Influenza Virus A/Puerto Rico/8/1934 H1N1 as a Model for Influenza Vaccine Antigens
Previous Article in Special Issue
An Overview of Recent Developments in the Application of Antigen Displaying Vaccine Platforms: Hints for Future SARS-CoV-2 VLP Vaccines
 
 
Article

Article Versions Notes

Vaccines 2023, 11(10), 1521; https://doi.org/10.3390/vaccines11101521
Action Date Notes Link
article xml file uploaded 25 September 2023 08:20 CEST Original file -
article xml uploaded. 25 September 2023 08:20 CEST Update https://www.mdpi.com/2076-393X/11/10/1521/xml
article pdf uploaded. 25 September 2023 08:20 CEST Version of Record https://www.mdpi.com/2076-393X/11/10/1521/pdf
article supplementary file uploaded. 25 September 2023 08:20 CEST - https://www.mdpi.com/2076-393X/11/10/1521#supplementary
article html file updated 25 September 2023 08:22 CEST Original file https://www.mdpi.com/2076-393X/11/10/1521/html
Back to TopTop